Literature DB >> 15334074

CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation.

Jill R Crittenden1, Wolfgang Bergmeier, Yanyu Zhang, Crystal L Piffath, Yuqiong Liang, Denisa D Wagner, David E Housman, Ann M Graybiel.   

Abstract

Signaling through the second messengers calcium and diacylglycerol (DAG) is a critical element in many biological systems. Integration of calcium and DAG signals has been suggested to occur primarily through protein kinase C family members, which bind both calcium and DAG. However, an alternative pathway may involve members of the CalDAG-GEF/RasGRP protein family, which have structural features (calcium-binding EF hands and DAG-binding C1 domains) that suggest they can function in calcium and DAG signal integration. To gain insight into the signaling systems that may be regulated by CalDAG-GEF/RasGRP family members, we have focused on CalDAG-GEFI, which is expressed preferentially in the brain and blood. Through genetic ablation in the mouse, we have found that CalDAG-GEFI is crucial for signal integration in platelets. Mouse platelets that lack CalDAG-GEFI are severely compromised in integrin-dependent aggregation as a consequence of their inability to signal through CalDAG-GEFI to its target, the small GTPase Rap1. These results suggest that analogous signaling defects are likely to occur in the central nervous system when CalDAG-GEFI is absent or compromised in function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334074     DOI: 10.1038/nm1098

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  158 in total

1.  Rap1-Rac1 circuits potentiate platelet activation.

Authors:  Lucia Stefanini; Yacine Boulaftali; Timothy D Ouellette; Michael Holinstat; Laurent Désiré; Bertrand Leblond; Patrick Andre; Pamela B Conley; Wolfgang Bergmeier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 2.  Extracellular matrix proteins in hemostasis and thrombosis.

Authors:  Wolfgang Bergmeier; Richard O Hynes
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 3.  Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation.

Authors:  Alexander Zarbock; Tibor Kempf; Kai C Wollert; Dietmar Vestweber
Journal:  J Mol Med (Berl)       Date:  2011-11-19       Impact factor: 4.599

4.  Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling.

Authors:  Guoying Zhang; Binggang Xiang; Shaojing Ye; Magdalena Chrzanowska-Wodnicka; Andrew J Morris; T Kent Gartner; Sidney W Whiteheart; Gilbert C White; Susan S Smyth; Zhenyu Li
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

5.  Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.

Authors:  Jill R Crittenden; Ippolita Cantuti-Castelvetri; Esen Saka; Christine E Keller-McGandy; Ledia F Hernandez; Lauren R Kett; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

6.  A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding.

Authors:  Lucia Stefanini; Feng Ye; Adam K Snider; Kasra Sarabakhsh; Raymond Piatt; David S Paul; Wolfgang Bergmeier; Brian G Petrich
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

7.  The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism.

Authors:  Hao Zhang; Yu-Chung Chang; Mark L Brennan; Jinhua Wu
Journal:  J Mol Cell Biol       Date:  2013-11-28       Impact factor: 6.216

8.  A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans.

Authors:  Nikolay L Malinin; Li Zhang; Jeongsuk Choi; Alieta Ciocea; Olga Razorenova; Yan-Qing Ma; Eugene A Podrez; Michael Tosi; Donald P Lennon; Arnold I Caplan; Susan B Shurin; Edward F Plow; Tatiana V Byzova
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

9.  Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.

Authors:  Lena Svensson; Kimberley Howarth; Alison McDowall; Irene Patzak; Rachel Evans; Siegfried Ussar; Markus Moser; Ayse Metin; Mike Fried; Ian Tomlinson; Nancy Hogg
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

10.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.